YOLFTbeta
NeOnc Technologies Holdings, Inc. Common Stock

NeOnc Technologies Holdings, Inc. Common Stock

NTHI · NASDAQ · Healthcare / Biotechnology

4.91USD+0.06 (+1.24%)

Price History

Full chart

Market Stats

Previous Close4.85
Open4.98
Day Range4.68 – 5.24
52-Week Range2.96 – 12.99
Volume251.85K
Market Cap95.35M
P/E (TTM)0.00
Forward P/E0.00
EPS-2.12
Dividend Yield0.00%
50-Day Avg3.89
200-Day Avg6.24

About

NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Amir Farrokh Heshmatpour
  • Employees5
  • Headquarters23975 Park Sorrento, Calabasas, CA, United States, 91302, USA
  • Websitehttps://www.neonc.com

Leadership

  • Mr. Amir Farrokh HeshmatpourPresident, CEO, Executive Chairman & Secretary · b. 1967
  • Dr. Thomas C. Chen M.D., Ph.D.Founder, Chief Medical Officer, Chief Scientific Officer & Vice Chairman · b. 1965
  • Mr. Keithly A. GarnettChief Financial Officer · b. 1975
  • Dr. Josh Neman-Ebrahim Ph.D.Chief Clinical Officer · b. 1978
  • Mr. David Choi Jr.Chief Accounting Officer

Financials

Income Statement

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue020.00K70.46K83.00K39.99K
Growth (%)--+252.31%+17.79%-51.82%
Cost of Revenue--2.74M--
Gross Profit-20.00K70.46K83.00K39.99K
Gross Margin-100.00%100.00%100.00%100.00%
Operating Expense-2.86M12.27M7.23M58.21M
Operating Income-3.27M-2.84M-12.20M-7.14M-58.17M
Operating Margin--14188.02%-17310.99%-8605.45%-145459.36%
EBITDA-3.26M-2.85M-12.20M-9.10M-59.61M
EBITDA Margin--14233.02%-17310.99%-10958.39%-149050.22%
Net Income-3.38M-3.05M-14.92M-11.90M-62.15M
Net Income Margin--15233.78%-21176.05%-14335.50%-155404.38%
R&D674.56K1.16M1.53M3.05M3.64M
R&D as % of Total Revenue-5816.65%2177.22%3668.96%9097.92%
Interest Expense112.92K200.15K2.72M2.70M2.50M
Interest Expense % of Total Revenue-1000.76%3865.06%3255.60%6262.98%

Balance Sheet

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets32.49K728.68K1.27M3.42M2.82M
Total Liabilities2.65M2.30M15.25M8.92M20.33M
Total Equity-2.62M-1.58M-13.99M-5.50M-17.51M
Cash25.03K633.30K31.86K64.89K58.73K
Total Debt1.15M50.00K6.61M24.72K6.31M
Net Debt1.12M-583.30K6.57M-40.17K6.26M

Cash Flow

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-396.69K-881.74K-1.88M-4.21M-20.36M
Investing Cash Flow-----500.00K
Financing Cash Flow250.00K1.49M1.28M4.25M20.86M
Capital Expenditure3404500.00K
Free Cash Flow-396.69K-881.74K-1.88M-4.21M-20.86M
FCF to OCF100.00%100.00%100.00%100.00%102.46%

Earnings

Report DateFeb 26, 2025Jun 6, 2025Aug 18, 2025Nov 14, 2025Mar 31, 2026May 15, 2026Aug 10, 2026Nov 13, 2026
EPS Estimate0.00----0.37-0.14-0.16-0.30
EPS Actual-0.13-2.10-0.30-0.45-0.72-0.38-0.58-
Surprise-----93.46%-171.43%-262.50%-
Timing---Pre-marketPre-marketAfter-hoursPre-market-

Key Statistics & Ratios

Market Cap95.35M
Enterprise Value91.11M
Trailing P/E0.00
Forward P/E0.00
Price / Sales2384.24
Price / Book0.00
EPS-2.12
Book Value-0.872
Revenue (TTM)39.99K
Gross Profit (TTM)39.99K
Profit Margin0.00%
Operating Margin-104418.90%
Return on Equity0.00%
Return on Assets-634.99%
Shares Outstanding28.81M
Shares Float8.10M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
10.98%
Insiders
53.02%
Retail / Other
36.00%

Top Institutional Holders

  • Cinctive Capital Management LP
    1.43M6.57%
  • Bank of America Corp
    235.40K1.09%
  • Vanguard Capital Management, LLC
    215.70K0.99%
  • Westmount Partners, LLC
    197.18K0.91%
  • BlackRock Inc
    155.84K0.72%
  • Geode Capital Management, LLC
    126.85K0.58%
  • Susquehanna International Group, LLP
    91.04K0.42%
  • Vanguard Fiduciary Trust Co
    56.02K0.26%
  • Morgan Stanley - Brokerage Accounts
    51.92K0.24%
  • 683 Capital Management LLC
    50.00K0.23%
  • State Street Corp
    43.17K0.20%
  • The Goldman Sachs Group Inc
    35.58K0.16%
  • Global Retirement Partners, LLC.
    27.79K0.13%
  • Northern Trust Corp
    23.27K0.11%
  • Royal Bank of Canada
    16.63K0.08%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    310.60K1.20%
  • Fidelity Extended Market Index
    82.61K0.32%
  • iShares Micro-Cap ETF
    35.17K0.14%
  • Fidelity Total Market Index
    23.58K0.09%
  • Fidelity Series Total Market Index
    21.92K0.08%